×
Overview
Click Here to View the Program in Japanese
Membership is required to participate in DIA Community Day. Those whose membership qualifications have expired and non-members must apply after registering as members.
Program Committee
-
Goshi Ozawa, MS CEO
Real Discovery Outdorrs K.K., Japan -
Noriaki Nagao, MPHARM, PMP Pharmaceutical Division,Clinical Development Dept.
JAPAN TOBACCO INC., Japan -
Sonoko Misawa, MD, PHD Associate Professor, Department of Neurology
Chiba University Graduate of Medicine, Japan -
Taro Amagasaki, PHD Head, Analytics Japan
Novartis Pharma K.K., Japan -
Yuu Jincho, JD, MSC Clinical Operation & Platforms /Data Management & Strategy
GlaxoSmithKline K.K., Japan -
Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
Pfizer R&D Japan G.K., Japan -
Keiko Katsui, PHD Division of Biomedical Ethics and Social Co-Creation
Japan Agency for Medical Research and Development (AMED), Japan -
Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan GK, Japan -
Yukihiro Matsuda, MSC Director of Project Management
Linical Japan, Japan -
Kotone Matsuyama, RPH Center for Clinical Research and Development
National Center for Child Health and Development, Japan -
Hiroyuki Murakami, PHD Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Tomohiko Takahashi Associate Manager, Headquarters of Clinical Development
Otsuka Pharmaceutical Co., Ltd., Japan -
Tadashi Urashima, PHD Performance and Digital Analytics Lead, Japan Development
GlaxoSmithKline K.K., Japan
Have an account?